ABBOTT SEVOFLURANE INHALED ANESTHETIC NEPHROTOXICITY WARNING, POSTMARKETING STUDY RECOMMENDED BY FDA COMMITTEE; APPROVAL SUPPORTED DURING "NDA DAY"
Executive Summary
Abbott's inhaled anesthetic sevoflurane should carry a warning about nephrotoxicity findings in rat studies, FDA's Anesthetic & Life Support Drugs Advisory Committee recommended during a two-day "NDA Day" review Jan. 17-18.